Cardiac Biomarker Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4166352
- 119 Pages
- January 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Cardiac Biomarker market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Cardiac Biomarker market segmented into
Creatine kinase (CK) MB
Troponin (cTnI and cTnT)
BNP & NT-proBNP
Myogloblin
Ischemia Modified Albumin (IMA)
Others (hs-CRP, D-Dimer, etc.)
Based on the end-use, the global Cardiac Biomarker market classified into
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Based on geography, the global Cardiac Biomarker market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Siemens Healthcare
DiaDexus
BG Medicine
Singulex
Randox Laboratories
Thermo Scientific
Beckman Coulter
Abbott Laboratories
Roche Diagnostics
Response Biomedical
Critical Diagnostics
Alere
Becton
Bio-Rad Laboratories
Biomerieux
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CARDIAC BIOMARKER INDUSTRY
2.1 Summary about Cardiac Biomarker Industry
2.2 Cardiac Biomarker Market Trends
2.2.1 Cardiac Biomarker Production & Consumption Trends
2.2.2 Cardiac Biomarker Demand Structure Trends
2.3 Cardiac Biomarker Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Creatine kinase (CK) MB
4.2.2 Troponin (cTnI and cTnT)
4.2.3 BNP & NT-proBNP
4.2.4 Myogloblin
4.2.5 Ischemia Modified Albumin (IMA)
4.2.6 Others (hs-CRP, D-Dimer, etc.)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Myocardial Infarction
4.3.2 Congestive Heart Failure
4.3.3 Acute Coronary Syndrome
4.3.4 Atherosclerosis
4.3.5 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Creatine kinase (CK) MB
5.2.2 Troponin (cTnI and cTnT)
5.2.3 BNP & NT-proBNP
5.2.4 Myogloblin
5.2.5 Ischemia Modified Albumin (IMA)
5.2.6 Others (hs-CRP, D-Dimer, etc.)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Myocardial Infarction
5.3.2 Congestive Heart Failure
5.3.3 Acute Coronary Syndrome
5.3.4 Atherosclerosis
5.3.5 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Creatine kinase (CK) MB
6.2.2 Troponin (cTnI and cTnT)
6.2.3 BNP & NT-proBNP
6.2.4 Myogloblin
6.2.5 Ischemia Modified Albumin (IMA)
6.2.6 Others (hs-CRP, D-Dimer, etc.)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Myocardial Infarction
6.3.2 Congestive Heart Failure
6.3.3 Acute Coronary Syndrome
6.3.4 Atherosclerosis
6.3.5 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Creatine kinase (CK) MB
7.2.2 Troponin (cTnI and cTnT)
7.2.3 BNP & NT-proBNP
7.2.4 Myogloblin
7.2.5 Ischemia Modified Albumin (IMA)
7.2.6 Others (hs-CRP, D-Dimer, etc.)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Myocardial Infarction
7.3.2 Congestive Heart Failure
7.3.3 Acute Coronary Syndrome
7.3.4 Atherosclerosis
7.3.5 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Creatine kinase (CK) MB
8.2.2 Troponin (cTnI and cTnT)
8.2.3 BNP & NT-proBNP
8.2.4 Myogloblin
8.2.5 Ischemia Modified Albumin (IMA)
8.2.6 Others (hs-CRP, D-Dimer, etc.)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Myocardial Infarction
8.3.2 Congestive Heart Failure
8.3.3 Acute Coronary Syndrome
8.3.4 Atherosclerosis
8.3.5 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Creatine kinase (CK) MB
9.2.2 Troponin (cTnI and cTnT)
9.2.3 BNP & NT-proBNP
9.2.4 Myogloblin
9.2.5 Ischemia Modified Albumin (IMA)
9.2.6 Others (hs-CRP, D-Dimer, etc.)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Myocardial Infarction
9.3.2 Congestive Heart Failure
9.3.3 Acute Coronary Syndrome
9.3.4 Atherosclerosis
9.3.5 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Siemens Healthcare
10.1.2 DiaDexus
10.1.3 BG Medicine
10.1.4 Singulex
10.1.5 Randox Laboratories
10.1.6 Thermo Scientific
10.1.7 Beckman Coulter
10.1.8 Abbott Laboratories
10.1.9 Roche Diagnostics
10.1.10 Response Biomedical
10.1.11 Critical Diagnostics
10.1.12 Alere
10.1.13 Becton
10.1.14 Bio-Rad Laboratories
10.1.15 Biomerieux
10.2 Cardiac Biomarker Sales Date of Major Players (2017-2020e)
10.2.1 Siemens Healthcare
10.2.2 DiaDexus
10.2.3 BG Medicine
10.2.4 Singulex
10.2.5 Randox Laboratories
10.2.6 Thermo Scientific
10.2.7 Beckman Coulter
10.2.8 Abbott Laboratories
10.2.9 Roche Diagnostics
10.2.10 Response Biomedical
10.2.11 Critical Diagnostics
10.2.12 Alere
10.2.13 Becton
10.2.14 Bio-Rad Laboratories
10.2.15 Biomerieux
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Cardiac Biomarker Product Type Overview
2.Table Cardiac Biomarker Product Type Market Share List
3.Table Cardiac Biomarker Product Type of Major Players
4.Table Brief Introduction of Siemens Healthcare
5.Table Brief Introduction of DiaDexus
6.Table Brief Introduction of BG Medicine
7.Table Brief Introduction of Singulex
8.Table Brief Introduction of Randox Laboratories
9.Table Brief Introduction of Thermo Scientific
10.Table Brief Introduction of Beckman Coulter
11.Table Brief Introduction of Abbott Laboratories
12.Table Brief Introduction of Roche Diagnostics
13.Table Brief Introduction of Response Biomedical
14.Table Brief Introduction of Critical Diagnostics
15.Table Brief Introduction of Alere
16.Table Brief Introduction of Becton
17.Table Brief Introduction of Bio-Rad Laboratories
18.Table Brief Introduction of Biomerieux
19.Table Products & Services of Siemens Healthcare
20.Table Products & Services of DiaDexus
21.Table Products & Services of BG Medicine
22.Table Products & Services of Singulex
23.Table Products & Services of Randox Laboratories
24.Table Products & Services of Thermo Scientific
25.Table Products & Services of Beckman Coulter
26.Table Products & Services of Abbott Laboratories
27.Table Products & Services of Roche Diagnostics
28.Table Products & Services of Response Biomedical
29.Table Products & Services of Critical Diagnostics
30.Table Products & Services of Alere
31.Table Products & Services of Becton
32.Table Products & Services of Bio-Rad Laboratories
33.Table Products & Services of Biomerieux
34.Table Market Distribution of Major Players
35.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
36.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
37.Table Global Cardiac Biomarker Market Forecast (Million USD) by Region 2021f-2026f
38.Table Global Cardiac Biomarker Market Forecast (Million USD) Share by Region 2021f-2026f
39.Table Global Cardiac Biomarker Market Forecast (Million USD) by Demand 2021f-2026f
40.Table Global Cardiac Biomarker Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
